Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus kinetics and mathematical modeling.

Alan S Perelson1, Ruy M Ribeiro

  • 1Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. asp@lanl.gov

Seminars in Liver Disease
|June 12, 2004
PubMed
Summary

This review analyzes kinetic data from chronic hepatitis B virus (HBV) patients treated with lamivudine, adefovir dipivoxil, or combination therapy. Understanding treatment kinetics is crucial for managing HBV infection effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies.

bioRxiv : the preprint server for biology·2026
Same author

Towards modeling phage therapy.

PLoS computational biology·2026
Same author

INHERITANCE OF INTRACELLULAR VIRAL RNA IN A MULTISCALE MODEL OF HEPATITIS C INFECTION.

SIAM journal on applied mathematics·2026
Same author

AZD5582 robustly reactivates latently infected cells and clears the majority of those reactivated from the SIV reservoir.

bioRxiv : the preprint server for biology·2026
Same author

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

Clinical pharmacology and therapeutics·2026
Same author

Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect.

The Journal of experimental medicine·2025

Area of Science:

  • Virology
  • Pharmacokinetics
  • Hepatology

Background:

  • Chronic hepatitis B virus (HBV) infection poses a significant global health challenge.
  • Antiviral therapies are essential for managing HBV, but resistance and efficacy vary.
  • Accurate kinetic modeling aids in understanding drug action and patient response.

Purpose of the Study:

  • To review and interpret kinetic data from chronic HBV patients.
  • To evaluate treatment responses to lamivudine, adefovir dipivoxil, and combination therapy.
  • To provide insights into the modeling of antiviral drug kinetics in HBV infection.

Main Methods:

  • Review of published and clinical data on HBV kinetics.
  • Analysis of pharmacokinetic and pharmacodynamic data from treated patients.

Related Experiment Videos

  • Modeling of drug concentration-effect relationships.

    • Main Results:

    • Kinetic profiles differ among monotherapies and combination treatments.
    • Lamivudine and adefovir dipivoxil show distinct viral suppression patterns.
    • Combination therapy may offer enhanced kinetic control over viral replication.

    Conclusions:

    • Kinetic modeling is vital for optimizing antiviral strategies in chronic HBV.
    • Understanding individual patient kinetics can guide personalized treatment decisions.
    • Further research into kinetic data can improve long-term HBV management outcomes.